Cat.#: ACPP-1265
| Despition | EDG8 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1258 | Pannexin 1 Blocking Peptide (AC1258) | 250 µg | inquiry |
| ACPP-1640 | Human Human GDF11 Protein (AC1640) | 100 µg | inquiry |
| ACPP-1718 | Human ASRGL1 Protein (AC1718) | 2 µg | inquiry |
| ACPP-1087 | Recombinant Human IL-6 Protein (Fc Chimera 6xHis Tag) (AC1087) | 50 µg | inquiry |
| ACPP-1347 | Human HDL Protein (AC1347) | 10 mg | inquiry |
| ACPP-1123 | Recombinant Rat GFAP Protein (AC1123) | 25 µl | inquiry |
| ACPP-1562 | Human TAGLN3 Protein (AC1562) | 5 µg | inquiry |
| ACPP-1496 | Human SPINT2 Protein (AC1496) | 2 µg | inquiry |
| ACPP-1470 | Human CLTA Protein (AC1470) | 5 µg | inquiry |
| ACPP-1139 | Recombinant Human Cadherin 10 Protein (6×His Tag) (AC1139) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.